On how US President Donald Trump's protectionist policies may affect the IT and pharma stocks, Rahul Ajmera, CEO, US Office, IIFL Institutional Equities, said Trump has been in office for merely four weeks and it is too early to speculate.
first published: Feb 22, 2017 12:52 pm
A collection of the most-viewed Moneycontrol videos.
Live: Will Nifty's weakness continue for the second straight day? | Opening Bell
A money superpower you have in your 20s, not in 40s
Live: Nifty snaps 3-day gaining streak, slips below 26,300 on Venezuela tensions | Closing Bell
Live: Will US-Venezuela tensions derail Nifty's upmove? | Oil stocks in focus | Opening Bell
